Literature DB >> 22340593

Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73.

Hiroshi Katayama1, Jin Wang, Warapen Treekitkarnmongkol, Hidehiko Kawai, Kaori Sasai, Hui Zhang, Hua Wang, Henry P Adams, Shoulei Jiang, Sandip N Chakraborty, Fumio Suzuki, Ralph B Arlinghaus, Jinsong Liu, James A Mobley, William E Grizzle, Huamin Wang, Subrata Sen.   

Abstract

Elevated Aurora kinase-A expression is correlated with abrogation of DNA damage-induced apoptotic response and mitotic spindle assembly checkpoint (SAC) override in human tumor cells. We report that Aurora-A phosphorylation of p73 at serine235 abrogates its transactivation function and causes cytoplasmic sequestration in a complex with the chaperon protein mortalin. Aurora-A phosphorylated p73 also facilitates inactivation of SAC through dissociation of the MAD2-CDC20 complex in cells undergoing mitosis. Cells expressing phosphor-mimetic mutant (S235D) of p73 manifest altered growth properties, resistance to cisplatin- induced apoptosis, as well as premature dissociation of the MAD2-CDC20 complex, and accelerated mitotic exit with SAC override in the presence of spindle damage. Elevated cytoplasmic p73 in Aurora-A overexpressing primary human tumors corroborates the experimental findings. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22340593      PMCID: PMC3760020          DOI: 10.1016/j.ccr.2011.12.025

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  45 in total

1.  A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.

Authors:  S Sen; H Zhou; R A White
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

2.  Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model.

Authors:  Charles Walker; Stefanie Böttger; Ben Low
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

3.  TAp73alpha binds the kinetochore proteins Bub1 and Bub3 resulting in polyploidy.

Authors:  Patrizia Vernole; Michael H Neale; Daniela Barcaroli; Eliana Munarriz; Richard A Knight; Richard Tomasini; Tak W Mak; Gerry Melino; Vincenzo De Laurenzi
Journal:  Cell Cycle       Date:  2009-02-12       Impact factor: 4.534

Review 4.  A naturally occurring cancer with molecular connectivity to human diseases.

Authors:  Charles W Walker; Stefanie A Böttger
Journal:  Cell Cycle       Date:  2008-05-29       Impact factor: 4.534

5.  Dynamics of centromere and kinetochore proteins; implications for checkpoint signaling and silencing.

Authors:  Jagesh V Shah; Elliot Botvinick; Zahid Bonday; Frank Furnari; Michael Berns; Don W Cleveland
Journal:  Curr Biol       Date:  2004-06-08       Impact factor: 10.834

6.  Aurora kinase A inhibition leads to p73-dependent apoptosis in p53-deficient cancer cells.

Authors:  Altaf A Dar; Abbes Belkhiri; Jeffrey Ecsedy; Alexander Zaika; Wael El-Rifai
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

7.  Unattached kinetochores catalyze production of an anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding.

Authors:  Anita Kulukian; Joo Seok Han; Don W Cleveland
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

8.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

9.  Aurora A kinase activity influences calcium signaling in kidney cells.

Authors:  Olga V Plotnikova; Elena N Pugacheva; Erica A Golemis
Journal:  J Cell Biol       Date:  2011-06-13       Impact factor: 10.539

10.  A role of p73 in mitotic exit.

Authors:  Paola Merlo; Marcella Fulco; Antonio Costanzo; Rosamaria Mangiacasale; Sabrina Strano; Giovanni Blandino; Yoichi Taya; Patrizia Lavia; Massimo Levrero
Journal:  J Biol Chem       Date:  2005-06-28       Impact factor: 5.157

View more
  45 in total

Review 1.  Kinase signaling and targeted therapy for primary myelofibrosis.

Authors:  Qiong Yang; John D Crispino; Qiang Jeremy Wen
Journal:  Exp Hematol       Date:  2016-12-30       Impact factor: 3.084

2.  AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

Authors:  Ahmed Katsha; Janet Arras; Mohammed Soutto; Abbes Belkhiri; Wael El-Rifai
Journal:  Mol Oncol       Date:  2014-06-03       Impact factor: 6.603

3.  Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.

Authors:  Ahmed Katsha; Lihong Wang; Janet Arras; Omar M Omar; Jeffrey Ecsedy; Abbes Belkhiri; Wael El-Rifai
Journal:  Clin Cancer Res       Date:  2017-01-10       Impact factor: 12.531

Review 4.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

5.  AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma.

Authors:  Yadong Li; Jinsong Zhang
Journal:  Tumour Biol       Date:  2014-12-30

6.  Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.

Authors:  Warapen Treekitkarnmongkol; Hiroshi Katayama; Kazuharu Kai; Kaori Sasai; Jennifer Carter Jones; Jing Wang; Li Shen; Aysegul A Sahin; Mihai Gagea; Naoto T Ueno; Chad J Creighton; Subrata Sen
Journal:  Carcinogenesis       Date:  2016-09-13       Impact factor: 4.944

7.  TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.

Authors:  A K Thakur; J Nigri; S Lac; J Leca; C Bressy; P Berthezene; L Bartholin; P Chan; E Calvo; J L Iovanna; S Vasseur; F Guillaumond; R Tomasini
Journal:  Cell Death Differ       Date:  2016-03-04       Impact factor: 15.828

Review 8.  Aurora A kinase (AURKA) in normal and pathological cell division.

Authors:  Anna S Nikonova; Igor Astsaturov; Ilya G Serebriiskii; Roland L Dunbrack; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-08-03       Impact factor: 9.261

9.  Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1.

Authors:  Lihong Wang-Bishop; Zheng Chen; Ahmed Gomaa; Albert Craig Lockhart; Safia Salaria; Jialiang Wang; Keeli B Lewis; Jeffrey Ecsedy; Kay Washington; Robert Daniel Beauchamp; Wael El-Rifai
Journal:  Gastroenterology       Date:  2018-10-17       Impact factor: 22.682

10.  Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.

Authors:  Yangchun Xie; Shan Zhu; Meizuo Zhong; Manhua Yang; Xiaofan Sun; Jinbao Liu; Guido Kroemer; Michael Lotze; Herbert J Zeh; Rui Kang; Daolin Tang
Journal:  Gastroenterology       Date:  2017-07-29       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.